StockTipsArenaBeta

BUY Dr. Reddy's Laboratories Limited — Sumeet Bagadia, Choice Broking

BUYDr. Reddy's Laboratories Limited
Dr. Reddy's Laboratories share price target & all analyst calls

bySumeet Bagadia, Choice BrokingHorizon: NA (inferred Swing (≤2wk))12 Sept 2026via LiveMint Buy-or-Sell (topic)

Entry₹1,165Stated
Target₹1,290
Total upside +10.73% (call closed)
Stop loss₹1,100-5.58% risk
At expiry₹1,22128 Sept 2026, 3:30 pm
Expired+4.81%auction close
Follow Sumeet Bagadia for new calls(28% target hit, 416 closed calls)Get alertsWatch DRREDDY for new buy/sell callsGet alertsSee 6 active Swing calls on DRREDDYSee 209 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 28 Sept 2026
5 supporting1 opposing
Supports the BUY call (5)

5 advisors have active short-term BUY calls on this stock, with 3 issued in the last 14 days

Advisor consensus · adjacent horizon·28 Sept · today

2 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·28 Sept · today

Dr. Reddy's Laboratories has entered into an exclusive distribution and marketing agreement with Takeda Biopharmaceuticals India for Qdenga®, a dengue vaccine, in the private market in India. The agre

BSE · Company Update·18 Sept · 1w ago

(opens in new tab)

JM Financial sees up to 28% upside in Dr Reddy’s and Aurobindo Pharma. Should you buy?

NewsEt-Markets·16 Sept · 2w ago

(opens in new tab)

Dr Reddy's Mexico API facility gets 2 observations in US FDA records assessment

NewsCnbc-Tv18·11 Sept · 2w ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (1)

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDY

NewsGoogle News·10 Sept · 2w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Dr. Reddy's Laboratories

All analyst calls on Dr. Reddy's Laboratories

More from Sumeet Bagadia, Choice Broking

Every call and its outcome